You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ELEDON PHARMACEUTICALS INC

Eledon Pharmaceuticals Inc XNAS: ELDN

Eledon Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Download real time

3.35 -0.06 (-1.76%)

38.42% Fall from 52W High

179.3K XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The board meeting for Eledon Pharmaceuticals Inc is scheduled for today, for the purpose of Eledon Pharmaceuticals Inc Fourth Quarter Earnings Results for 2024 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
6.3 / 100
Momentum Score
Technically Neutral
44.6 / 100
Analyst Price Target
No estimates available

5

S

10

W

5

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Eledon Pharmaceuticals Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Eledon Pharmaceuticals Inc Stock Analysis

Eledon Pharmaceuticals Inc stock analysis with key metrics, changes, and trends.

Eledon Pharmaceuticals Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$36.18 M68.95%positive

Annual Net Profit rose 68.95% in the last year to $36.18 M. Its sector's average net profit growth for the last fiscal year was -32.45%.

Price to Earning Ratio-5.54-negative

Price to Earning Ratio is -5.54, which is negative.

Stock Price$3.3557.28%positive

Stock Price rose 57.28% and outperformed its sector by 51.72% in the past year.

Quarterly Net profit$44.62 M48.23%negative

Quarterly Net profit fell 48.23% YoY to $44.62 M. Its sector's average net profit growth YoY for the quarter was -47.41%.

Mutual Fund Holding10.85 %2.28%positive

Mutual Fund Holding increased by 2.28% in the last quarter to 10.85.

Promoter Share Holding0.20 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 0.2%.

Institutional Holding62.48 %31.52%positive

Institutional Holding increased by 31.52% in the last quarter to 62.48.

VIEW LESS


Loading data..

Eledon Pharmaceuticals Inc - Company Profile

What does Eledon Pharmaceuticals Inc do?

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals Inc Management structure

All Gross Remunerations are in USD
Dr. David-Alexandre C. Gros, M.D.
Director and Chief Executive Officer
2.55 M
2023
Gross Remuneration
Year
Dr. Steven N. Perrin, PhD
President, Chief Scientific Officer, Director
1.54 M
2023
Gross Remuneration
Year
Mr. Paul Sean Little
Chief Financial Officer and Principal Accounting Officer
1.32 M
2023
Gross Remuneration
Year
Mr. Bryan E. Smith
General Counsel, Corporate Secretary and Chief Compliance Officer
-
2023
Gross Remuneration
Year

Eledon Pharmaceuticals Inc Board of directors

All Gross Remunerations are in USD
Mr. Keith A. Katkin
Chairman of the Board
1.52 M
2023
Gross Remuneration
Year
Dr. June Lee, M.D.
Independent Director
374.44 K
2023
Gross Remuneration
Year
Mr. Walter C. Ogier
Independent Director
371.82 K
2023
Gross Remuneration
Year
Mr. John S. McBride
Independent Director
371.82 K
2023
Gross Remuneration
Year
Dr. Jan L. Hillson, M.D.
Independent Director
353.44 K
2023
Gross Remuneration
Year
Mr. Gary A. Lyons
Independent Director
337.69 K
2023
Gross Remuneration
Year

Eledon Pharmaceuticals Inc FAQ

How is Eledon Pharmaceuticals Inc today?
Eledon Pharmaceuticals Inc today is trading in the red, and is down by -1.76% at 3.35.
Eledon Pharmaceuticals Inc is currently trading down -1.76% on an intraday basis. In the past week the stock fell -2.62%. stock has been down -22.63% in the past quarter and rose 57.28% in the past year. You can view this in the overview section.